Bepotastine/montelukast(Hyundai Pharmaceutical)

N/A

Report date: 2024/11/20 20:00:31

Base Information

Drug NameBepotastine/montelukast(Hyundai Pharmaceutical)
Drug Alias NameHDDO-18011/HDDO-18012
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonistsCysteinyl leukotriene receptor 1 antagonists
TargetsHistamine H1 receptorCysteinyl leukotriene receptor 1
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHyundai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHyundai Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Tract Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A